Table 3. Phenotypical features of sporadic patients investigated (N=58).
BRCA1 mutation-positive patients |
BRCA2 mutation-positive patients |
Mutation positive patients |
||||
---|---|---|---|---|---|---|
N | % | N | % | N | % | |
41 female breast cancer patients (mean Dx 33.5, median Dx 33, range 26–52) | 2 | 4.9 | 1 | 2.4 | 3 | 7.3 |
Six patients with multiple primary breast cancers (bilateral or multifocal) (mean Dx first breast cancer 39.8, median Dx 39.5, range 31–50) | 0 | 0 | 0 | 0 | 0 | 0 |
Five ovarian cancer patients (mean Dx 35.4, median Dx35, range 25–52) | 0 | 0 | 0 | 0 | 0 | 0 |
Two patients with both primary breast and ovarian cancer (mean Dx breast cancer 52.5 (range 50–55); mean Dx ovarian cancer 50 (range 47–53) | 1 | 50 | 0 | 0 | 1 | 50 |
Four male breast cancer patients (mean Dx 49.3, median Dx 58.5, range 12–68) | 0 | 0 | 0 | 0 | 0 | 0 |
58 sporadic patients | 3 | 5.2 | 1 | 1.7 | 4 | 6.9 |
Dx=age at diagnosis (years).